SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM) announced total revenue for the fourth quarter of 2015 is expected to be in the range of approximately $30 million and $31 million based on preliminary, unaudited financial data. Total revenue for the full year of 2015 is expected to be in the range of approximately $114 […]
HERCULES, Calif. & SAN DIEGO — Bio-Rad Laboratories, Inc. (NYSE: BIO) (NYSE: BIOb) andIllumina, Inc. (NASDAQ: ILMN) today announced an exclusive partnership to develop the most comprehensive next-generation sequencing (NGS) workflow for single-cell analysis. The end-to-end commercial solution will enable high-throughput sequencing of thousands of individual cells, traditionally a challenging, costly and time-consuming process. Most […]
OMAHA, Neb. — Transgenomic, Inc. (NASDAQ: TBIO), a global biotechnology company advancing precision medicine through advanced diagnostic tests and clinical and research services, today announced that it raised gross proceeds of approximately $2.2 million in a preferred stock and warrant private placement financing with existing investors Crede Capital Group, LLC and Third Security, LLC. Through […]
DELRAY BEACH, Fla. — PositiveID Corporation (“PositiveID” or “Company”) (PSID), a life sciences company focused on detection and diagnostics, announced today a summary of 2015 highlights and its outlook for 2016 following two recent acquisitions. Highlights Acquired E-N-G Mobile Systems, Inc., a growing business focused on mobile biological and chemical labs, with strong market share […]
OMAHA, Neb. — Transgenomic, Inc. (NASDAQ: TBIO), a global biotechnology company advancing precision medicine through advanced diagnostic tests and clinical and research services, today announced that it has moved to simplify and strengthen its capital structure by entering into a conversion agreement with the holders of its outstanding Series A and Series B convertible preferred […]
OMAHA, Neb. — Transgenomic, Inc. (NASDAQ: TBIO), a global biotechnology company advancing precision medicine through advanced diagnostic tests and clinical and research services, today announced that it has been awarded a two-year Small Business Technology Transfer (STTR) grant by the US National Institutes of Health (NIH). The $1.5 million grant will fund a collaborative project […]
Madrid, Spain and Heidelberg, Germany – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced that it has signed three additional non-exclusive distribution agreements with PhileKorea, Pharma Tech Korea and Axil Scientific for the commercialization of SYGNIS’ proprietary product portfolio in Korea and Singapore and thereby significantly expands its Asian footprint. With these agreements, […]
PLEASANTON, Calif. — Roche (SIX: RO, ROG; OTCQX: RHHBY) announced regulatory clearance to finalize acquisition of Kapa Biosystems, Inc. (Kapa), a privately-held company headquartered in Wilmington, Massachusetts, US. Kapa Biosystems is a provider of genomic tools in the life sciences sector that employs proprietary technologies to optimize enzymes for next-generation sequencing (NGS), as well as […]
KKR announced that it has agreed to acquire LGC, the international life sciences measurement and testing company, from its current owners Bridgepoint, for an undisclosed amount. KKR will partner with LGC to provide capital and operational support to facilitate future growth. LGC provides a range of measurement products and services which underpin the safety, health […]
LGC, the international life sciences company creating measurement and testing solutions for companies across the world, is to be sold by Bridgepoint for an undisclosed sum to KKR. Owned by Bridgepoint since 2010, LGC operates globally in 22 countries and focuses on three distinct areas: the manufacture and distribution of reference materials, proprietary genomic products […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
